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Identification of a Novel Role of T Cells in
Postnatal Vasculogenesis
Characterization of Endothelial Progenitor Cell Colonies
Jin Hur, PhD*; Han-Mo Yang, MD*; Chang-Hwan Yoon, MD*; Choon-Soo Lee, MS;
Kyung-Woo Park, MD; Ji-Hyun Kim, MS; Tae-Youn Kim, MS; Ju-Young Kim, MS;
Hyun-Jae Kang, MD; In-Ho Chae, MD; Byung-Hee Oh, MD;
Young-Bae Park, MD; Hyo-Soo Kim, MD
Background—The colony number of early endothelial progenitor cells (EPCs) has been used as a quantitative indicator
of the number of EPCs in the blood or as a biological marker of cardiovascular diseases. In the present study, we found
a subset of T cells that were localized at the center of the EPC colony and played a pivotal role in colony formation and
differentiation of early EPCs.
Methods and Results—We found that CD3CD31CXCR4 T cells (referred to as angiogenic T cells in the present study)
constituted the center of EPC colonies during cultures of human peripheral blood mononuclear cells. These angiogenic
T cells were required for colony formation and differentiation of early EPCs. They secreted high levels of angiogenic
cytokines such as vascular endothelial growth factor, interleukin-8, and matrix metalloproteinases. Angiogenic T cells
showed superior angiogenic potential to the other subset of T cells in the experiments with regard to Matrigel tube
formation, adhesion, transendothelial migration, and collagen invasion assay, mainly through the stromal cell–derived
factor 1/CXCR-4 axis. Furthermore, angiogenic T cells enhanced endothelial cell proliferation and function. In vivo
study showed that angiogenic T cells play an important role in the process of vessel formation. Clinical study showed
that the level of angiogenic T cells in the peripheral blood was well correlated with EPC colony numbers and had inverse
relationships with age and the number of risk factors for coronary artery disease.
Conclusions—These findings suggest that angiogenic T cells could be a potential therapeutic target for ischemic
cardiovascular diseases. (Circulation. 2007;116:1671-1682.)
Key Words: lymphocytes  cells  angiogenesis  cytokines
In 1997, Asahara and colleagues1 demonstrated that CD34

hematopoietic progenitor cells from peripheral blood
mononuclear cells can differentiate into endothelial lineage
cells. Since then, many studies have shown that these cells,
termed endothelial progenitor cells (EPCs), play an important
role in neovascularization.2,3 In particular, peripheral blood
mononuclear cells cultured in vitro usually form EPC colo-
nies that are called colony-forming unit endothelial cells
(CFU-ECs or CFU-EPCs). They consist of a central cluster of
round cells and multiple spindle-shaped cells (which are
regarded as early EPCs) that emanate from this central
cluster.4–6 Hill and colleagues4 showed that the number of
CFU-EPCs, which was regarded as a quantitative variable for
EPCs in the blood, might be a surrogate biological marker for
cardiovascular risk and vascular function; however, we
and others have shown that early EPCs are a heterogeneous
group of cells that most likely enhance angiogenesis by
secreting cytokines such as vascular endothelial growth
factor (VEGF), interleukin (IL)-8, and matrix metallopro-
teinase (MMP)-9.7–11
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To date, no studies have been conducted that have charac-
terized the heterogeneous cells that compose the early EPC
colony and the role of cells other than EPCs in postnatal
vasculogenesis. It is well known that hematopoietic cells
support proliferation and differentiation of endothelial cells
and EPCs during both embryonic vascular development and
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angiogenesis.12 Considering these facts, we hypothesized that
the center of EPC colonies may be composed of other
hematopoietic cells.
In the present study, we report for the first time that the
central cluster of EPC colonies is mainly composed of a
specific subpopulation of T cells, CD3CD31CXCR4 T
cells. We also studied the cell biological characteristics of
these T cells and their role in regulating early EPC differen-
tiation and endothelial cell function. Next, we examined the
role of angiogenic T cells in in vivo models. Finally, we
investigated the clinical implication of these T cells by
analyzing the correlation between the level of these T cells
and cardiovascular risk factors.
Methods
All materials and methods used for experimental procedures can be
found in the online-only Data Supplement.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
The Central Cell Cluster of EPC Colonies Is
Mainly Composed of T Cells
On the basis of our hypothesis that a certain type of hematopoi-
etic cell may form the center of EPC colonies, we stained the
EPC colony with various hematopoietic cell surface markers
(Figure I, online-only Data Supplement). Among these, the
strongest positive marker was CD3, a well-known surface
marker for T cells (Figure 1a through 1c). The area negative for
CD3 was composed mainly of spindle-shaped cells, which were
positive for 1,1’-dioctadecyl-3,3,3’,3’-tetramethylin-
docarbocyanine perchlorate–labeled acetylated low-density li-
poprotein (DiI-acLDL), indicating early EPCs. To confirm that
the central cluster of EPC colonies is composed of CD3 cells,
we performed coculture of CD3-depleted mononuclear cells
(MNCs) and CFSE-labeled CD3 cells. After 7 days of cocul-
ture, we found that CD3 cells were located at the center of EPC
colonies (Figure 1d through 1f).
Next, whole MNCs were divided into 3 groups and were
cultivated as follows: intact whole MNCs, CD3-depleted MNCs,
and CD3 T-cell group. On day 7, the whole-MNC group
showed cell clusters with sprouting spindle-shaped EPCs (Fig-
ure 1g and 1j), but the CD3-depleted MNC group did not (Figure
1h and 1k), which suggests that CD3 cells are required for
optimal differentiation of EPCs. On day 10, spindle-shaped cells
started to appear in the CD3-depleted MNC group. Interestingly,
the CD3 cell group showed nonadherent round cell clusters but
not spindle-shaped EPCs during the entire culture period (Figure
1i through 1l), which indicates that CD3 cells did not directly
differentiate into early EPCs.
Phase Contrast
Whole MNCs Whole MNCs - CD3 CD3 only







Figure 1. Identification of CD3 cells local-
ized at the central part of human EPC colo-
nies. A through c, When we stained EPC
colonies (a) with various types of surface
markers of hematopoietic cells, the central
part of EPC colonies was stained mainly
with anti-CD3 FITC antibody (b). The
remaining part, which shows spindle-shaped
cells, was stained with DiI-acLDL (c). Scale
bar, 100 m. d through f, After 7 days of
coculture of CD3-depleted MNCs and
CFSE-labeled CD3 cells, CD3 cells were
located at the center of the EPC colony.
Scale bar, 100 m. g through i, After 7 days
of culture, the whole-MNC group showed
clusters with spindle-shaped EPCs (g),
whereas the CD3-depleted MNC group
showed neither clusters nor spindle-shaped
EPCs (h). On day 10, spindle-shaped EPCs
started to appear in the CD3-depleted MNC
group (data not shown). CD3 cells showed
only cell clusters (i).
j through l, High magnification of Figure 1g,
1h, and 1i, respectively. Arrow indicates
spindle-shaped cells. Scale bar, 200 m.
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CD3CD31 T Cells but Not CD3CD31
T Cells Constitute the Central Cell Cluster
of EPC Colonies
To characterize these CD3 cells in more detail, we per-
formed fluorescence-activated cell sorter analysis and char-
acterized these cells using various markers at multiple time
points (Figure 2a). In the case of CD34, CD133, the kinase
insert domain-containing receptor (KDR), and vascular endo-
thelial cadherin (VE-cadherin), the fraction of cells that were
positive for these markers was so small that it would be
unlikely that these cells would make up the entire center of
EPC colonies; however, the CD31 fraction was relatively
high and was maintained during culture. On the basis of these
results, we stained the colonies again and found that the
central clusters of EPC colonies were positive for CD31 and
for CD4 and CD8 (Figure 2b).
To isolate CD3CD31 T cells, we performed multistep
magnetic activated cell sorting (Figure II, online-only Data
Supplement). After CD3 selection with magnetic activated
cell sorting, we separated CD3 cells into 2 groups using
CD31 antibody and magnetic beads: CD3CD31 double-
positive (DP) T cells and CD3CD31 single-positive (SP) T
cells. When we performed confocal microscopy, CD31 was
evenly expressed on the surface of a DP cell but not on the
surface of an SP cell (Figure III, online-only Data
Supplement).
After isolation, we compared DP cells with SP cells. When
we cultivated these DP and SP cells separately, DP cells
started to form multiple round cell clusters, whereas SP did
not form any clusters (Figure 2c). To determine whether DP
cells could incorporate into the preformed EPC clusters, we
added CFSE-labeled DP or SP cells onto whole MNCs that
were already cultivated. After 1 day, DP cells incorporated
into the center of preformed EPC colonies, whereas SP cells
did not (Figure 2d). In another experiment in which CFSE-
labeled DP cells were cocultured with DP-depleted entire
MNCs, DP cells were located at the center of EPC colonies
on day 7 (Figure 2e).
CD3CD31 T Cells Are Required for EPC
Colony Formation and Early EPC Differentiation
To assess the essential role of DP cells in EPC colony
formation, we compared colony formation between intact
whole MNCs and DP-depleted whole MNCs. After 5 days of
culture, in the whole-MNC group, we observed colonies with
spindle-shaped EPCs; however, the DP-depleted group did
not show any colony or spindle-shaped EPCs (Figure 3a).
Interestingly, when we added DP cells to DP-depleted MNCs,
we observed the formation of EPC colonies, which suggests
that DP cells can rescue the EPC cluster-forming capability
(data not shown). On day 10, spindle-shaped EPCs appeared
in DP-depleted MNCs. Their number, however, was signifi-
cantly fewer than that in the whole-MNC group, which
suggests that DP cells are necessary for early EPC
differentiation.
The time of first appearance of spindle-shaped EPCs was
significantly delayed in the DP-depleted group compared
with the whole-MNC group by 5 days (Figure 3b). Moreover,
levels of KDR and VE-cadherin, differentiation markers of
EPCs, were significantly decreased in DP-depleted MNCs
(Figure 3c and 3d). Matrigel tube formation assay with
human umbilical vein endothelial cells (HUVECs) showed
that the DP-depleted group lacked functional differentiation
compared with the whole-MNC group (Figure 3e). These
results suggest that DP cells play a very important role in
early EPC differentiation. From this point on, we refer to DP
cells as “angiogenic T cells.”
CD3CD31 T Cells Show Better Proangiogenic
Characteristics Than CD3CD31 T Cells
We compared the immunologic and angiogenic features of
DP cells with those of SP cells. The range of percentage of
DP cells among T cells was from 33% to 61%, and the mean
value was 46% in normal volunteers (n8). Forty-four
percent of these DP cells were CD4, and 46% were CD8.
Because stromal cell–derived factor 1 (SDF-1) has an impor-
tant role in the homing and migration of hematopoietic stem
cells into the ischemic region,13 we compared the expression
of CXCR4, a receptor for SDF-1. Most DP cells expressed
CXCR4, whereas only a small portion of SP cells expressed
CXCR4 (DP versus SP, 97.6% versus 37.6%).
Levels of various proangiogenic cytokines in the culture
supernatants were compared between DP and SP cells.
Whereas SP cells secreted minimal levels of cytokines, DP
cells secreted much higher levels of proangiogenic cytokines
such as VEGF, IL-8, IL-17, and granulocyte colony–stimu-
lating factor (Figure 4a). Moreover, DP cells secreted higher
levels of MMP-9, which is known to play an important role in
angiogenesis, than did SP cells, whereas DP and SP cells
equally secreted MMP-2 (Figure 4b).14,15
Next, we investigated functional differences between DP
and SP cells in their interaction with endothelial cells, such as
capillary tube formation, adhesion, transendothelial migra-
tion, and collagen invasion. Tube formation assay on GFR
growth factor reduced Matrigel matrix showed that DP cells
incorporated with HUVECs and helped HUVECs form sig-
nificantly more complete capillary tubes than SP cells (Figure
4c and 4d). Adhesion assay showed that DP cells had a higher
capacity for adhesion on HUVECs than SP cells (Figure 4e).
In a transendothelial migration assay, DP cells migrated more
than SP cells toward SDF-1 in the lower chamber. Blocking
of CXCR4 with a neutralizing antibody significantly de-
creased the extent of migration, which suggests that transen-
dothelial migration of DP cells depends on the SDF-1/
CXCR4 axis (Figure 4f).
To assess both transendothelial migration and invasion
capacity, we performed a modified vertical collagen gel assay
(Figure IVa, online-only Data Supplement). Confocal micros-
copy showed DP cells transmigrating through the HUVEC
monolayer (Figure IVb, online-only Data Supplement). DP
cells showed a greater collagen invasion capacity toward
SDF-1 than SP cells (Figure IVc, online-only Data Supple-
ment), which was neutralized by blocking antibody against
CXCR4 (Figure IVd, online-only Data Supplement).
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Figure 2. CD3CD31 DP T cells, but not CD3CD31 SP T cells, constitute the central part of human EPC colonies. a, Serial changes
in each surface marker in CD3 T cells when MNCs were cultivated in endothelial cell growth media. Except for CD31, the fraction of
other marker-positive cells was so small that these cells would be unlikely to form the entire center of EPC colonies. The values in the
graph represent the percentage of each type of marker-positive cells in each gated CD3 T-cell subset. The horizontal axis shows CD3
positivity, and the vertical axis shows the positivity of each marker. Data are presented as meanSEM (n8). b, Immunofluorescence
staining of CD3, CD4, CD8 (green), and CD31 (red) in EPC colonies. The center of the EPC cluster was stained with CD4, CD8, and
CD31. CD31 area appeared more diffuse than CD3 area due to the surrounding EPCs, which were also positive for CD31. Scale bar,
100 m. c through e, To confirm that CD3CD31 DP T cells localize at the center of the EPC colony, we performed 3 different
(Continued)
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Figure 2 (Continued). experiments. c, Comparison between CD3CD31 DP cells and CD3CD31 SP cells. Areas in upper panels are
magnified in middle panels. When we cultivated these CFSE-labeled DP and SP cells separately in endothelial cell growth media, DP
cells started to form multiple round cell clusters, whereas SP cells did not form any clusters. Lower panels are fluorescence photomi-
crographs of middle panels that show CFSE-labeled cells (green). Scale bar, 200 m. d, One day after the addition of CFSE-labeled DP
or SP cells to whole MNCs already cultured, DP cells could incorporate into the center of the preformed EPC colony, but SP cells
could not. Lower panels show fluorescence photomicrographs of upper panels. Scale bar, 100 m. e, After coculture with DP cell-
depleted whole MNCs, CFSE-labeled DP cells were located at the center of EPC colonies on day 7. Scale bar, 100 m. From these


































Figure 3. Effects of CD3CD31 (DP) T cells
on EPC differentiation. a, We compared
DP-depleted whole MNCs with intact whole
MNCs with the same cell number. After 5
days of culture, in the whole-MNC group, we
observed a colony with spindle-shaped EPCs;
however, in the DP-depleted group, we did
not see any colony with spindle-shaped EPCs
(upper panel). On day 10 of cultivation, in the
whole-MNC group, we saw more spindle-
shaped cells. In the DP-depleted group, we
saw fewer spindle-shaped cells (lower panel).
Arrows indicate spindle-shaped EPCs. Scale
bar, 100 m. b, To quantify this, we exam-
ined time to first appearance of spindle-
shaped EPCs. The appearance of spindle-
shaped cells was delayed in DP-depleted
MNCs by 5 days compared with intact whole
MNCs. Data are presented as meanSEM
(n5). c and d, In fluorescence-activated cell
sorter analysis of surface markers such as
KDR (c) and VE-cadherin (d), which are
known to be differentiation markers of EPCs,
the level of such surface molecules
decreased in DP-depleted MNCs compared
with whole MNCs. Data are presented as
meanSEM (n5). e, Tube formation assay
using coculture with HUVECs showed that
depletion of DP cells decreased the ability of
tube formation compared with the whole
MNCs. Data are presented as meanSEM
(n5).
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Figure 4. Comparison between DP cells and SP cells. a, Cytokine level of IL-8, VEGF, IL-17, and granulocyte colony–stimulating factor
(G-CSF) secreted from either DP cells or SP cells. Whereas SP cells secreted the minimal level of cytokines, DP cells secreted a much
higher level of proangiogenic cytokines. b, Moreover, gelatin zymography showed that DP cells expressed an increased level of
MMP-9, which is known to play an important role in angiogenesis. c and d, When we performed a tube formation assay on Matrigel
with the coculture of either DP cells or SP cells (both are labeled with CFSE) and HUVECs, DP cells showed significantly more com-
plete tube formation with HUVECs than SP cells (c). Interestingly, DP cells could not incorporate into the tube itself but attached to the
tube formed by HUVECs (d). Scale bar, 50 m. e, Adhesion assay showed that DP cells had greater adhesion capacity than SP cells.
Data are presented as meanSEM (n5). f, Result of transendothelial migration (TEM) assay. DP cells in the upper chamber showed
more migration through the endothelial monolayer toward SDF-1 in the lower chamber. Overall, DP cells showed a greater capability for
transendothelial migration than SP cells. When we blocked CXCR4 using blocking antibody (Ab), the extent of migration decreased,
which suggests that transendothelial migration of DP cells depends on the SDF-1/CXCR4 axis.
1676 Circulation October 9, 2007
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CD3CD31 T Cells Enhance Proliferation,
Migration, and Capillary Tube Formation of
Endothelial Cells
Neovascularization includes not only recruitment of EPCs
(vasculogenesis) but also proliferation of preexisting en-
dothelial cells (angiogenesis). To evaluate the effects of
cytokines secreted by DP and SP cells on proliferation of
endothelial cells, we performed a WST-1 assay using
conditioned medium of both cells. We found that DP-
conditioned media significantly increased proliferation
compared with SP-conditioned media (Figure Va, online-
only Data Supplement). When we added a mixture of
neutralizing antibodies against IL-8 and VEGF, this pro-
liferation decreased significantly. In addition, DP-
conditioned media enhanced the migration of endothelial
cells and capillary tube formation more than SP-
conditioned media, and this result was attenuated by
neutralizing antibodies against IL-8 and VEGF (Figure Vb
and Vc, online-only Data Supplement).
Angiogenic T Cells Participate in New Vessel
Formation In Vivo
To investigate the role of angiogenic T cells in angiogenesis
in vivo, we performed Matrigel plug assay by injecting a
mixture of Matrigel and SDF-1 into the subcutaneous tissue
of normal BALB/c mice. On day 3, a few MNCs infiltrated
into the Matrigel plug (Figure 5b), which included T cells as
indicated by brown CD3 cells. On day 10, the number of
infiltrating MNCs increased with new vessel-like structures
(Figure 5c), and with meticulous observation, it could be seen
that CD3 cells surrounded the vessel-like structures (Figure
5d and 5e). Double immunohistochemistry showed that the
CD3 cells were also positive for CD31 (Figure 5f), which
suggests that these DP angiogenic T cells participate in new
vessel formation in vivo. To compare the angiogenic capacity
of DP versus SP cells in vivo, we performed another
experiment in which we introduced either DP or SP cells in
Matrigel plug into nude mice. Plugs with DP cells showed
more new vessel formation than those with SP cells, as shown
by their more vascularized and reddish gross appearance
(Figure 5g).
Angiogenic T Cells Can Restore the Impaired
Angiogenic Capacity of Nude Mice
To examine whether angiogenic T cells can rescue the
impaired angiogenic potential of nude mice, we tested these
cells in a hind limb ischemia model. Mice were randomly
assigned to 1 of 4 groups: media-injected normal BALB/c
mice, media-injected nude mice, DP-injected nude mice, and
SP-injected nude mice. The group of nude mice showed
much-delayed recovery of blood flow in ischemic hind limb
compared with normal BALB/c mice (Figure 6a and 6b).
Nude mice receiving DP cells systemically showed a higher
recovery of blood flow than those receiving SP cells or
media. In addition, capillary density increased markedly in
DP-injected mice compared with SP- or media-injected mice
(Figure 6c). In contrast, transplantation of SP cells could not
improve the recovery of blood flow compared with control
nude mice injected with media. When we evaluated the tissue
of ischemic hind limb in DP-injected mice, we found that the
level of SDF-1 in the perivascular area increased and that
















Figure 5. In vivo angiogenic capacity of angio-
genic T cells. We first performed Matrigel plug
assay in vivo by injecting a mixture of Matrigel
and SDF-1 into subcutaneous tissue of normal
BALB/c mouse. a through c, Serial representa-
tive figures of each time point are shown. a, On
day 1, no cell infiltration was present. Scale bar,
100 m. b, On day 3, some MNCs infiltrated
into the Matrigel plug. Immunohistochemical
staining for CD3 (brown) showed that among
these cells, some CD3 cells were present.
Scale bar, 50 m. c, On day 10, in the Matrigel
plug, many cells and some vessel-like struc-
tures were present. Scale bar, 100 m. d,
Higher magnification of area in (c) showed that
CD3 cells (brown) surrounded the vessel-like
structures. Scale bar, 50 m. e, Another higher
magnification of a vessel-like structure. CD3
cells (brown) surrounded the vessel-like struc-
ture. On the luminal side of endothelial cells,
some cells like red blood cells were present.
Scale bar, 50 m. f, Double-
immunohistochemical staining in an adjacent
section of the same tissue shown in (e) revealed
that CD3 cells (brown) were also stained with
reddish CD31. Endothelium-lining area was also
stained with reddish CD31. These results sug-
gest that the cells surrounding the vessel-like
structure might be CD3CD31 angiogenic T
cells. Scale bar, 50 m. g, After mixing Matrigel
and DP or SP cells, we injected Matrigel plug
into subcutaneous tissue of nude mouse.
DP-injected plugs show more reddish gross
appearance than SP-injected plugs.
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Figure 6. In vivo angiogenic capacity of angiogenic T cells. a, Quantitative analysis of perfusion recovery by laser Doppler perfusion
analysis. Hindlimb ischemia was created in each group, and 1106 CFSE-labeled cells were delivered systemically by intracardiac
injection. Media-injected nude mice showed much-delayed recovery of blood flow compared with normal BALB/c mice. Nude mice
receiving DP cells showed a significant improvement in blood flow recovery to ischemic hindlimb compared with nude mice injected
with SP cells or media. In contrast, SP injection in nude mice showed little effect on recovery compared with media-injected nude
mice. n10 for each group. These results suggest that, in contrast to SP cells, angiogenic T cells can restore the impaired angiogenic
(Continued)
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was strongly expressed (Figure 6d). To confirm the in vivo
angiogenic potential of angiogenic T cells, we compared
angiogenic potential between whole MNCs and DP cell-
depleted MNCs after 7 days’ culture. The capability for blood
flow recovery by whole MNCs was significantly impaired by
depletion of angiogenic T cells from MNCs (Figure 6e),
which suggests that the depletion of angiogenic T cells
impairs angiogenic potential in vivo.
Angiogenic T Cells Are Correlated With the
Number of CFU-EPCs and Are Inversely
Correlated With Cardiovascular Risk Factors
To evaluate the clinical correlation of angiogenic T cells with
CFU-EPCs, we counted the number of angiogenic T cells and
the number of CFU-EPCs simultaneously in 40 healthy
volunteers. As the level of angiogenic T cells in blood
increased, the number of cultured CFU-EPCs increased
(Figure 7a). Interestingly, an inverse correlation existed
between angiogenic T cells and age (Figure 7b).
To evaluate the clinical relevance of angiogenic T cells to
cardiovascular risk, we analyzed the relationship between
cardiovascular risk factors and the percentage of angiogenic
T cells in peripheral blood MNCs in 58 subjects, including
patients who underwent coronary angiography. We found that
the percentage of angiogenic T cells decreased as Framing-
ham risk scores increased (Figure 7c). In patients with many
risk factors, however, the relationship was not evident.
Discussion
The present study demonstrated that human CD3CD31
CXCR4 T cells constitute the central cluster of EPC colo-
nies. This subset of T cells, termed “angiogenic T cells,” was
critical in the formation of EPC colonies. Furthermore,
angiogenic T cells enhanced the differentiation of early EPCs
and potentiated the function of both early EPCs and endothe-
lial cells by secreting angiogenic cytokines. Moreover, in
vivo studies showed that angiogenic T cells play an important
role in the process of new vessel formation. In addition, the
number of angiogenic T cells in blood was correlated with the
number of EPC colonies cultured from human peripheral
blood and was significantly influenced by donor’s age and
cardiovascular risk factors.
T Cells Localized at the Center of the EPC Colony
Asahara et al1 described that EPC colonies were composed of
round cells clustered at the center and sprouting spindle-
shaped cells at the periphery. Moreover, the EPC colony or
CFU-EPCs recently have been used as a quantitative variable
for EPCs in peripheral blood and have been regarded as a
cardiovascular prognostic factor.4,5 Considering the growing
importance of the CFU-EPC in cardiovascular research, we
investigated the characteristics of the EPC colony in detail.
We expected that the central cluster might contain hemato-
poietic lineage cells, and we found that the central round
cells mainly consisted of a specific subset of T cells
(CD3CD31CXCR4). Furthermore, we proved that this
subset of T cells was necessary for the formation of an EPC
colony by depleting or adding these T cells during EPC
culture, which suggested an important role of T cells in early
EPC differentiation.
A Novel Role of T Cells in Early EPC
Differentiation and Angiogenesis
Stabile et al16,17 recently reported that T cells regulated
angiogenesis in vivo. After they induced hind limb ischemia
in mice, they observed that CD4 and CD8 T cells infiltrated
into the ischemic tissue. They suggested that VEGF and
macrophage recruitment controlled by T cells was the mech-
anism by which T cells affect angiogenesis. We evaluated the
role of T cells not only in early EPC differentiation during
culture but also in endothelial function in vitro for the first
time in the present study. These results implied that the subset
of T cells might be important regulators in postnatal vascu-
logenesis and angiogenesis, not just incidental bystanders.
Theoretically, we can divide the process of neovascular-
ization into multiple steps, such as EPC mobilization, its
homing to the ischemic zone via adhesion, transendothelial
migration and invasion, and then formation of new vessels by
EPCs and preexisting endothelial cells.18 From the results of
the present study, we can postulate that angiogenic T cells
expressing high levels of CXCR4 home to areas of ischemia
where SDF-1 level is high. Then, these angiogenic T cells
may easily attach to the endothelial cells, transmigrate
through the endothelial junction using CD31, and then invade
the ischemic tissue using MMP-9. Angiogenic T cells are supposed
to facilitate early EPC differentiation and stimulate the local
resident endothelial cells by secreting angiogenic cytokines
such as VEGF and IL-8. Angiogenic T cells could enhance
neovascularization by orchestrating all these processes to-
gether (Figure VI, online-only Data Supplement).
CD31 Was a Specific Marker for T Cells With
Vasculogenic Potential
We demonstrated that CD31 T cells showed better angio-
genic capacity than other subsets of T cells. CD31 (also
known as platelet/endothelial cell adhesion molecule-1, or
PECAM-1) is not a specific marker of endothelial cells. It is
also expressed on leukocytes and platelets19 and is known to
modulate leukocyte transmigration and angiogenesis.20,21
Figure 6 (Continued). capacity of nude mice. b, Representative pictures of each group. Left picture shows intact hindlimb in normal
BALB/c mouse, whereas right picture shows amputated hindlimb of nude mouse. c, Consistent with the results of blood flow recovery in
each group, capillary density was markedly increased in DP-injected mice compared with either SP-injected or media-injected mice. Scale
bar, 100 m. d, The tissue of ischemic hindlimb of DP-injected nude mice showed that the level of SDF-1 (red) was high in the perivascular
area where CFSE-labeled DP cells (green) were located. Scale bar, 50 m. e, We compared angiogenic potential between whole MNCs (W)
and DP cell-depleted MNCs (W-DP) after 7 days’ culture. The capability of blood flow recovery by whole MNCs was significantly impaired by
depletion of angiogenic T cells from MNCs, which suggests that depletion of angiogenic T cells impairs angiogenic potential in vivo. n10 for
each group.
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Figure 7. Clinical relevance of angiogenic
T cells. a, Association between angiogenic
T cells and EPC colonies. After isolating
MNCs from 40 normal volunteers, we
examined the relation between angiogenic
T cells and the number of EPC colonies
after 7 days of culture. As the level of
angiogenic T cells increased, the number
of CFU-EPCs increased. b, Association
between angiogenic T cells (Ang-T) and
age. An inverse relationship existed
between angiogenic T cells and age in
normal volunteers. n40. c, Relation
between angiogenic T cells and cardiovas-
cular risk. As Framingham risk score
increased, the percentage of angiogenic T
cells in the peripheral blood decreased in
patients with coronary artery disease. The
percentage of angiogenic T cells indicates
the fraction of both CD3 and CD31 cells
in the lymphogate for fluorescence-acti-
vated cell sorter analysis. n58.
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Taken together, these facts suggest that CD31 T cells may
easily interact with or pass through endothelial cells via
CD31-mediated interaction in contrast to CD31 T cells.
Moreover, in the process of passage, the intracellular signal
pathway of these angiogenic T cells might be activated by
CD31 and thus show an enhanced angiogenic effect.22
Angiogenic T Cells as a Potential Biomarker in
Cardiovascular Disease
Hill et al4 previously showed an inverse relationship between
the number of EPC colonies and cardiovascular risk factors.
In the present study, we found that angiogenic T cells in
peripheral blood were well correlated with EPC colonies and
appeared to reflect the number of EPC colonies. Furthermore,
we found an inverse relationship of angiogenic T cells with
age and cardiovascular risk factors, although patients with
multiple risk factors showed a lesser correlation. Therefore,
angiogenic T cells may be used as a new biological marker
for cardiovascular disease and endothelial function.
The CFU-EPC in vitro assay is the standard method to
quantitate the number of early EPCs in the circulating blood.
However, colony formation in vitro is influenced by angio-
genic T cells; therefore, in future studies, a CFU-EPC assay
should be performed and evaluated in association with
angiogenic T cells.
Other Considerations
One question that can be raised is by which mechanism
angiogenic T cells facilitate early EPC differentiation. We
could consider 2 mechanisms: One is a paracrine effect by
proangiogenic cytokines, and the other is cell-to-cell direct
interaction between angiogenic T cells and EPCs. The present
study showed that angiogenic T cells produce multiple
proangiogenic cytokines. During EPC culture, we routinely
observed the phenomenon that spindle-shaped EPCs first
emerged only around the EPC colonies where a high-
concentration state of angiogenic cytokines by angiogenic T
cells could be formed first.
These angiogenic T cells might have other roles in differ-
ent situations, such as atherosclerosis. For example, Caligiuri
et al23,24 showed that CD31 T cells play an important
regulatory role in the pathogenesis of plaque thrombosis and
the development of aortic aneurysm.
In conclusion, the present study reports for the first time
the presence of a novel subpopulation of T cells that consti-
tute the central cell cluster of EPC colonies and that can
enhance EPC differentiation and angiogenesis, resulting in
neovascularization in vivo. Considering the clinical relevance
of angiogenic T cells, it may be of interest to investigate the
feasibility of these cells as an important surrogate marker of
cardiovascular risk factors and as a therapeutic target for
patients with ischemic heart disease.
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CLINICAL PERSPECTIVE
It is known that the number of endothelial progenitor cell colonies is related not only to the level of endothelial progenitor
cells but also to cardiovascular prognosis. The present study demonstrated that the level of angiogenic T cells correlated
significantly with the number of EPC colonies. Moreover, angiogenic T cells showed a significant inverse correlation with
age and cardiovascular risk factors. Therefore, angiogenic T cells could be used as a novel putative biological marker for
cardiovascular disease and vascular function. In addition, it would be very helpful to increase the number of angiogenic
T cells locally in the ischemic region in patients with ischemic heart disease. There might be other roles for angiogenic T
cells. In terms of stem cell biology, angiogenic T cells could facilitate differentiation of other stem cells by secretion of
cytokines or by direct cell-to-cell interaction. In addition, recent studies have shown that T cells might be very important
in the initiation and development of tumors such as breast cancers, colorectal cancers, and ovarian cancers through the
stromal cell–derived factor 1/CXCR4 axis. Because angiogenic T cells may participate in this tumor angiogenesis,
angiogenic T cells could be good therapeutic targets for cancer therapy. Given these facts, further studies of angiogenic T
cells could have a considerable clinical impact.
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Supplemental Figure 3









CFSE (green) : cytosol staining for DP cells 
SNARF (red)  : cytosol staining for SP cells
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